Candriam SCA’s Alpine Immune Sciences Inc ALPN Stock Holding History

Candriam SCA’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-415,000	Closed	-$16.5M	–	734
2024 Q1	$16.5M	Sell	415,000 -55,000	-12%	-$1.62M	0.11%	193
2023 Q4	$8.96M	Buy	+470,000	New	+$6.53M	0.06%	263

Candriam SCA's ALPN Position: Q2 2024 in Review

Candriam SCA sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 415,000 shares — an estimated $16.5M sold.

Candriam SCA first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $16.5M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Candriam SCA reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Candriam SCA sold 415,000 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $16.5M.
Candriam SCA first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
Candriam SCA's Alpine Immune Sciences Inc position peaked at $16.5M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.